Table 1

Risk of recurrent ischaemic stroke and haemorrhagic complications in the ProFESS trial

Events on aspirin and ER-DPEvents on clopidogrelHR (95% CI)
Risk of recurrent ischaemic stroke916 (9.0%)898 (8.8%)1.01 (0.92 to 1.11)
Major haemorrhage419 (4.1%)365 (3.6%)1.15 (1.00 to 1.32)
Intracranial haemorrhage147 (1.4%)103 (1.0%)1.42 (1.11 to 1.83)
  • Adapted from Sacco et al.1

  • ER-DP, extended-release dipyridamole; PRoFESS, Prevention Regimen for Effectively Avoiding Second Strokes.